Drug pricing and transparency in Europe and the United States: what is it and how does it work?-Reference-Cited by-同舟云学术

Drug pricing and transparency in Europe and the United States: what is it and how does it work?

Published:2024-01-26 Issue: Volume: Page:1-10
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Simoens Steven¹,Toumi Mondher²³

Affiliation:

1. KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium

2. Department of Public Health, Aix Marseille University, Marseille, France

3. Inovintell, Krakow, Poland

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2024.2311302

Reference87 articles.

1. Webb E Richardson E Vogler S et al. What are the implications of policies increasing transparency of prices paid for pharmaceuticals? A primer for understanding the policy perspective in light of the empirical evidence Copenhagen (Denmark). World Health Organization; 2022. https://eurohealthobservatory.who.int/publications/i/what-are-the-implications-of-policies-increasing-transparency-of-prices-paid-for-pharmaceuticals

2. Drug price transparency initiative: The need for a broader view

3. Barrenho E Lopert R. Exploring the consequences of greater price transparency on the dynamics of pharmaceutical markets 2022. https://www.oecd-ilibrary.org/content/paper/c9250e17-en

4. Bentata P Czech M Greiner W et al. The consequences of greater net price transparency for innovative medicines in Europe: searching for a consensus. London: Charles River Associates; 2020. https://www.researchgate.net/publication/347356137_The_consequences_of_greater_Net_Price_Transparency_for_innovative_medicines_in_Europe_Searching_for_a_consensus

5. Drug price transparency initiative: A scoping review